This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23; On-demand experience Delivered September 28-30Boston Convention and Exhibition Center

Michael Skynner, Ph.D.
Chief Operating Officer at Bicycle Therapeutics


Michael Skynner, Ph.D., is chief operating officer at Bicycle Therapeutics responsible for global operations, the platform, discovery and strategic alliances. He has over 22 years of pharm/biotech experience and joined Bicycle in 2016 from Pfizer, where he led rare disease efforts in Europe and founded both the Pfizer Rare Disease Consortium & Genetic Medicine Institute. Previously, he established a discovery performance unit at GSK focused on developing clinical small-molecule therapeutics targeting inflammatory kinases. Prior to GSK he co-founded a successful peptide-based biotech start-up company, Cambridge Biotechnology Ltd., which was sold to Swedish Orphan Biovitrum.

Agenda Sessions

  • FEATURED MINI-SYMPOSIUM AND LIVE PANEL DISCUSSION WITH LIVE Q&A: Targeted Delivery of Oligonucleotides: Tissue-Specific Challenges and Novel Conjugation Strategies


Speakers at this event